Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The Journal of Prevention of Alzheimer'S Disease|June 25, 2023
Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task ForceD Angioni, O Hansson, R J Bateman, et al.The Journal of Prevention of Alzheimer'S Disease|October 25, 2022
Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task ForceD Angioni, J Delrieu, O Hansson, et al.The Journal of Prevention of Alzheimer'S Disease|May 6, 2024
Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical TrialsH Liu, J Li, E Ziegemeier, et al.Medrxiv : the Preprint Server for Health Sciences|April 5, 2023
Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer diseaseL Vermunt, C Sutphen, E Dicks, et al.Revue Neurologique|September 11, 2013
Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trialS M Mills, J Mallmann, A M Santacruz, et al.Pageof 2